HealthEdge Invests in Specialty Pharmacy Nursing Network (SPNN)

Option Care Health Acquires Specialty Pharmacy Nursing Network (SPNN) from HealthEdge

April 12, 2022

Healthcare Services

Option Care Health (Nasdaq: OPCH) acquired Specialty Pharmacy Nursing Network (SPNN), a national provider of specialty home infusion nursing services, from HealthEdge Investment Partners. The deal expands Option Care Health's nursing platform and access to clinical resources across the United States as part of its continued consolidation of home and alternate-site infusion services.

HealthEdge and Synergistic Capital Partners Invest in Today's Dental Network

July 13, 2021

Dental

HealthEdge Investment Partners and Synergistic Capital Partners completed an investment in Today's Dental Network (TDN), a multi-specialty concierge dental practice network supporting 17 locations across Southwest Florida. The capital and partnership will support TDN’s growth plan to expand via additional partnership and specialty practice acquisitions while providing centralized practice-management services and technology.

Nautic Partners Makes Growth Investment in SPS Health

February 4, 2022

Healthcare Services

Nautic Partners has made a strategic growth investment in SPS Health to support the company's continued investment in technology, clinical and operational solutions for post-acute pharmacies and PBMs. The capital from Nautic (from its tenth fund) will help SPS expand its technology-enabled offerings and broaden its reach across long-term care, behavioral health, correctional and other specialty pharmacy markets.

HealthEdge Acquires Legacy-Xspire Holdings, LLC

December 18, 2019

Pharmaceuticals

HealthEdge Investment Partners, a Tampa-based healthcare-focused private equity firm, completed an acquisition of Legacy-Xspire Holdings, LLC, a Ridgeland, Mississippi-based branded and generic pharmaceutical marketing and distribution platform, on December 18, 2019. The deal adds a pharmaceutical marketing and distribution capability (combining WraSer Pharmaceuticals, Gentex Pharma, and Xpsire Pharma) to HealthEdge's portfolio to support organic growth and product acquisitions across the U.S.

HealthEdge Investment Partners Invests in Anodyne

April 25, 2022

Medical Devices

HealthEdge Investment Partners completed a platform investment in Anodyne, a provider of lifestyle-oriented clinical footwear and custom orthotics most commonly prescribed for diabetic patients. HealthEdge will partner with Anodyne to accelerate growth, expand distribution and scale the company's in-house manufacturing capabilities.

Enhanced Healthcare Partners Invests in NeuroPsychiatric Hospitals

September 30, 2020

Healthcare Services

Enhanced Healthcare Partners, a healthcare-focused private equity firm, announced an investment in NeuroPsychiatric Hospitals to support the company's expansion of integrated inpatient neuropsychiatric services. The capital will be used to accelerate geographic expansion (including planned openings in Arizona and Texas) and to scale NPH's interdisciplinary care model across additional hospitals nationwide.